Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Clinical trial NCT04794101 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04794101
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-04
- Primary completion
- 2029-09-20
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.